MARISOL GANDEE: Open Payments
NPI 1700510567 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$830 in 17 payments from 8 companies in 2025. Trend: 2023 $910 · 2024 $556 · 2025 $830
Food & beverage: $830
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 2 | $250 |
| ARGENX US, INC. | 3 | $153 |
| UCB, Inc. | 2 | $140 |
| Axsome Therapeutics, Inc. | 3 | $137 |
| ABBVIE INC. | 4 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Celgene Corporation | 1 | $22 |
| Lundbeck LLC | 1 | $20 |
Products named: Briviact, Symbravo, VYVGART, ULTOMIRIS, UBRELVY, VYVGART HYTRULO, HYQVIA, ZEPOSIA.
Industry payments across WI — which companies pay providers there.
